Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans
- PMID: 9378841
- DOI: 10.1002/j.1552-4604.1997.tb04356.x
Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans
Abstract
Twelve healthy volunteers received oral placebo, 250 mg of caffeine, and 500 mg of caffeine in a randomized, double-blind, single-dose crossover study. Caffeine kinetics were nonlinear, with clearance significantly reduced and elimination half-life prolonged at the 500-mg compared to the 250-mg dose. The lower dose of caffeine produced more favorable subjective effects than the higher dose (elation, peacefulness, pleasantness), whereas unpleasant effects (tension, nervousness, anxiety, excitement, irritability, nausea, palpitations, restlessness) following the 500-mg dose exceeded those of the 250-mg dose. The lower dose of caffeine enhanced performance on the digit symbol substitution test and a tapping speed test compared to placebo; high-dose caffeine produced less performance enhancement than the lower dose. The plasma concentration versus response relationship revealed concentration-dependent increases in anxiety and improvements in cognitive and motor performance at low to intermediate concentrations. Both caffeine doses reduced electroencephalographic amplitude over the 4 Hz to 30 Hz spectrum, as well as in the alpha (8-11 Hz) and beta (12-30 Hz) ranges; however, effects were not dose-dependent. While favorable subjective and performance-enhancing stimulant effects occur at low to intermediate caffeine doses, the unfavorable subjective and somatic effects, as well as performance disruption, from high doses of caffeine may intrinsically limit the doses of caffeine used in the general population.
Similar articles
-
Psychomotor performance: investigating the dose-response relationship for caffeine and theophylline in elderly volunteers.Eur J Clin Pharmacol. 1998 Jun;54(4):309-13. doi: 10.1007/s002280050465. Eur J Clin Pharmacol. 1998. PMID: 9696955 Clinical Trial.
-
Fluvoxamine impairs single-dose caffeine clearance without altering caffeine pharmacodynamics.Br J Clin Pharmacol. 2005 Nov;60(5):486-93. doi: 10.1111/j.1365-2125.2005.02467.x. Br J Clin Pharmacol. 2005. PMID: 16236038 Free PMC article. Clinical Trial.
-
Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness.J Sleep Res. 2008 Sep;17(3):309-21. doi: 10.1111/j.1365-2869.2008.00654.x. Epub 2008 Jun 2. J Sleep Res. 2008. PMID: 18522689 Clinical Trial.
-
Behavioral effects of caffeine and other methylxanthines on children.Exp Clin Psychopharmacol. 1998 Feb;6(1):87-95. doi: 10.1037//1064-1297.6.1.87. Exp Clin Psychopharmacol. 1998. PMID: 9526149 Review.
-
Caffeine as an attention enhancer: reviewing existing assumptions.Psychopharmacology (Berl). 2013 Jan;225(2):251-74. doi: 10.1007/s00213-012-2917-4. Epub 2012 Dec 16. Psychopharmacology (Berl). 2013. PMID: 23241646 Review.
Cited by
-
Effects of Different Caffeine Dosages on Maximal Physical Performance and Potential Side Effects in Low-Consumer Female Athletes: Morning vs. Evening Administration.Nutrients. 2024 Jul 11;16(14):2223. doi: 10.3390/nu16142223. Nutrients. 2024. PMID: 39064667 Free PMC article. Clinical Trial.
-
Acute Effects of Caffeine Ingestion on Postural Balance, Functional Capacity and Cognitive Function in Patients with End Stage Renal Disease.Brain Sci. 2024 Jul 13;14(7):701. doi: 10.3390/brainsci14070701. Brain Sci. 2024. PMID: 39061441 Free PMC article.
-
Acute exposure to caffeine improves foraging in an invasive ant.iScience. 2024 May 23;27(6):109935. doi: 10.1016/j.isci.2024.109935. eCollection 2024 Jun 21. iScience. 2024. PMID: 39055608 Free PMC article.
-
Effects of caffeine on temporal perception in Rattus norvegicus.PLoS One. 2024 May 31;19(5):e0304608. doi: 10.1371/journal.pone.0304608. eCollection 2024. PLoS One. 2024. PMID: 38820365 Free PMC article.
-
Paraxanthine provides greater improvement in cognitive function than caffeine after performing a 10-km run.J Int Soc Sports Nutr. 2024 Dec;21(1):2352779. doi: 10.1080/15502783.2024.2352779. Epub 2024 May 9. J Int Soc Sports Nutr. 2024. PMID: 38725238 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical